Who founded Gelsana Therapeutics?

Gelsana Therapeutics was founded by Melissa Krebs.

Who are Gelsana Therapeutics's investors?

Gelsana Therapeutics's investors include Innosphere Ventures, MINES VENTURE.

How much funding has Gelsana Therapeutics raised?

Gelsana Therapeutics has disclosed $3.5M raised across 1 round.

Where is Gelsana Therapeutics headquartered?

Gelsana Therapeutics is headquartered in Aurora, US.

Gelsana Therapeutics

Aurora, US · Delaware corporation · 2 known investors

gelsanatherapeutics.com ↗

GelSana Therapeutics develops zwitterionic polymer-based biomaterials for wound care, addressing excess sustained inflammation that impedes healing. Its first product, CleraFlex, is a shelf-stable wound dressing designed to reduce inflammation, repel bacteria, balance moisture, and provide a protective barrier.

BiotechHealthtechMedical DevicesNew Materials

Founders & leadership

Melissa KrebsinFounder and CEO

Donald GregginChief Commercial Officer

Adam RockerinDirector R&D

Vicki AbbasinExecutive Director Clinical Operations

Ania CamplininFractional CFO

Board

Mike Freeman inBoard directorGeneral Partner at Innosphere Ventures

Diana Verrilli inBoard directorGeneral Manager, Navista (a Cardinal Health company) at Oncology Ventures

Investors · 2

Innosphere Ventures✓ verifiedFort Collins

MINES VENTUREGolden

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2023

▶$3.5MraisedMar 2026 · 20 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Mike FreemanDirector
Diana VerrilliDirector
Melissa KrebsExecutive Officer, Director

Offering amount: $3.7M
Amount sold: $3.5M
First sale: Nov 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Sanara MedTech6 shared keywordsSanara MedTech is a medical technology company focused on wound care and related healthcare products. The page lists its board of directors and executive leadership.

Organogenesis3 shared keywordsOrganogenesis is a regenerative medicine company that develops and commercializes products for the advanced wound care and surgical biologics markets, supplying clinicians and their patients. Its product portfolio includes tissue-based therapies such as Apligraf for wound care.

Companies competing with Gelsana Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2023	$299.6K
U.S. Air ForceAir Force	Phase I	2023	$75K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Gelsana Therapeutics do?: GelSana Therapeutics develops zwitterionic polymer-based biomaterials for wound care, addressing excess sustained inflammation that impedes healing. Its first product, CleraFlex, is a shelf-stable wound dressing designed to reduce inflammation, repel bacteria, balance moisture, and provide a protective barrier.
Who founded Gelsana Therapeutics?: Gelsana Therapeutics was founded by Melissa Krebs.
Who are Gelsana Therapeutics's investors?: Gelsana Therapeutics's investors include Innosphere Ventures, MINES VENTURE.
How much funding has Gelsana Therapeutics raised?: Gelsana Therapeutics has disclosed $3.5M raised across 1 round.
Where is Gelsana Therapeutics headquartered?: Gelsana Therapeutics is headquartered in Aurora, US.